Artelo Biosciences (ARTL) awards stock options to director Douglas Blayney
Rhea-AI Filing Summary
ARTELO BIOSCIENCES granted director Douglas Blayney a stock option for 136 shares of common stock at an exercise price of $1.15 per share, expiring on July 17, 2036. The option vests 100% on the earlier of one year after the Vesting Commencement Date of July 17, 2026, or the day prior to the next annual stockholders’ meeting, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Blayney Douglas
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 136 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 136 shares (Direct)
Footnotes (1)
- F1. Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026.
Key Figures
Options Granted: 136 shares
Exercise Price: $1.1500 per share
Underlying Shares: 136 shares
+3 more
6 metrics
Options Granted
136 shares
Stock Option (right to buy) awarded to director Douglas Blayney
Exercise Price
$1.1500 per share
Conversion or exercise price of the stock option
Underlying Shares
136 shares
Underlying common stock covered by the option
Expiration Date
2036-07-17
Option expiration date as reported
Vesting Percentage
100%
All shares vest on the earlier of the two specified vesting triggers
Vesting Commencement Date
July 17, 2026
Defined Vesting Commencement Date for the option award
Key Terms
Stock Option (right to buy), Vesting Commencement Date, Service Provider
3 terms
Stock Option (right to buy) financial
"Security title is reported as Stock Option (right to buy)"
Vesting Commencement Date financial
"Vesting Commencement Date shall mean July 17, 2026"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Service Provider financial
"subject to the Reporting Person continuing to be a Service Provider"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did ARTELO BIOSCIENCES (ARTL) report for Douglas Blayney?
ARTELO BIOSCIENCES reported a stock option grant to director Douglas Blayney for 136 shares of common stock. The option has a fixed exercise price, long-dated expiration, and a time-based vesting schedule tied to service and a future annual meeting.
How many stock options were granted in the ARTL Form 4 for Douglas Blayney?
Douglas Blayney received a grant of 136 stock options, each representing the right to buy one share of ARTELO BIOSCIENCES common stock. All 136 options are reported as held directly after the transaction, indicating a newly awarded equity position.
What is the exercise price and expiration date of the ARTL options granted to Douglas Blayney?
The options have an exercise price of $1.15 per share and expire on July 17, 2036. This long expiration gives an extended period during which the director can choose to exercise, subject to the vesting and continued service conditions.
When do the ARTELO BIOSCIENCES (ARTL) options granted to Douglas Blayney vest?
All options vest 100% on the earlier of one year after the Vesting Commencement Date of July 17, 2026, or the day before the next annual stockholders’ meeting after that date, provided he remains a Service Provider through the applicable vesting date.
Is the ARTL Form 4 transaction for Douglas Blayney a purchase or an award?
The Form 4 reports a grant/award acquisition of stock options, coded as an “A” transaction. This indicates a compensation-related award rather than an open-market purchase or sale, with no cash price paid at grant and a specified exercise price for future use.